
A Position Statement on Bone Marrow Stem Cells as Homologous Use
In March, the Pain Physician Journal published a position statement from the American Society of Interventional Pain Physicians (ASIPP). TOBI faculty, Dr. Christopher Centeno, and other contributing authors hope this review will aid regulators overseeing regenerative musculoskeletal medicine. Their objective being to provide a comprehensive, focused, review of literature describing the current regulatory guidelines and definition of “homologous use,” ASIPP shows that bone marrow concentrate (BMC) meets such criteria. Statement 1: Based on a review of literature in discussing the...